Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

La Jolla Pharmaceutical Company (LJPC)

6.63   -0.13 (-1.92%) 03-25 13:54
Open: 6.73 Pre. Close: 6.76
High: 6.86 Low: 6.36
Volume: 396,956 Market Cap: 180M

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 7.138 - 7.196 7.196 - 7.235
Low: 6.623 - 6.685 6.685 - 6.727
Close: 6.679 - 6.775 6.775 - 6.839

Technical analysis

as of: 2019-03-25 1:31:16 PM
Stoxline posted a SELL today, same as yesterday. Downward movement continues.
Target: Six months: 9.13     One year: 10.67
Support: Support1: 6.40    Support2: 5.52
Resistance: Resistance1: 7.82    Resistance2: 9.13
Pivot: 7.07
Moving Average: MA(5): 7.00     MA(20): 6.77
MA(100): 9.69     MA(250): 20.12
MACD: MACD(12,26): 0.14     Signal(9): 0.15
Stochastic oscillator: %K(14,3): 51.22     %D(3): 61.77
RSI: RSI(14): 47.38
52-week: High: 38.39  Low: 5.01  Change(%): -77.6
Average Vol(K): 3-Month: 103625  10-Days: 68212

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
LJPC has closed above bottom band by 10.2%. Bollinger Bands are 68.9% narrower than normal. The narrow width of the bands suggests low volatility as compared to LJPC's normal range. The bands have been in this narrow range for 2 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Tue, 05 Mar 2019 01:11:56 Z
La Jolla Pharmaceutical Co (LJPC) Q4 2018 Earnings Conference Call Transcript

Fri, 11 Jan 2019 17:06:51 Z
Friday 1/11 Insider Buying Report: HIG, LJPC

Tue, 08 Jan 2019 04:38:33 Z
Here's Why La Jolla Pharmaceutical Tumbled Today

Mon, 07 Jan 2019 23:59:00 Z
CFRX Fails To Impress, LJPC Falls On Giapreza Outlook, AXGN Disappoints

Thu, 25 Oct 2018 00:10:04 Z
La Jolla Pharmaceutical (LJPC) Reports Q3 Loss, Tops Revenue Estimates

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Google+ Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 27.08
Shares Float (M) 25.48
% Held by Insiders 6.10
% Held by Institutions 167.90
Shares Short (K)
Shares Short P. Month (K)

Stock Financials

EPS -7.900
EPS Est. Current Year -4.990
EPS Est. Next Year -3.970
EPS Est. Next Quarter -1.420
Forward EPS -2.611
Book Value (p.s.) 6.560
PEG Ratio -0.11
Profit Margin
Operating Margin -1881.97
Return on Assets (ttm) -123.2
Return on Equity (ttm) -359.9
Qtrly Rev. Growth
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.)
Qtrly Earnings Growth
Operating Cash Flow (M) -152.37
Levered Free Cash Flow (M) -79.11

Stock Valuations

P/E -0.84
P/E Growth Ratio -0.01
P/BV 1.02
P/S 451559008.00
P/CF -1.19

Dividends & Splits

Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date 2014-01-14
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2019 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.